Autologous Stem Cell Transplantation and Maintenance Therapy for Multiple Myeloma
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This trial will determine the feasibility and efficacy of lenalidomide as maintenance therapy
in Multiple Myeloma patients treated with dose intensive chemotherapy (Melphalan 200 mg/m2)
with autologous PBSC transplant.